Summer 2025

Lab automation: New Modalities

More visitors, more exhibitors and more new product launches at SLAS Europe in Hamburg.

Highlights included the latest developments in CRISPR automation, toxicity and phenotypic screening in human 3D cell aggregates and the presentation of a completely new protease-resistant and highly specific oral drug class.

In this Focus:

  • Finding new leads and modalities automatically
  • Spiroligomer molecules: advancing drug design
  • Remote controls for immunotherapies

ADVERTISEMENT

Other issues

Special Summer 2025
Special Summer 2025
Special Spring 2025
Special Winter 2025
Special Winter 2025
Special Winter 2025

ADVERTISEMENT

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!